Vimarsana
Biggest News Aggregation in the World

Page 18 - Immunization Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunization Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunization Practice Today - Breaking & Trending Today

RSV infection responsible for up to 10,000 deaths among older adults per year in the US: CDC - Vimarsana News

RSV infection responsible for up to 10,000 deaths among older adults per year in the US: CDC

Acknowledging the RSV risk among senior citizens, CDC recommends people aged 60 years and older to get a dose of RSV vaccine this fall after discussing with their healthcare provider. TheHealthSite.com

Statement from HHS Secretary Xavier Becerra on CDC's Historic Recommendation Allowing Older and Immunocompromised Adults to Receive the RSV Vaccine - Vimarsana News

Statement from HHS Secretary Xavier Becerra on CDC's Historic Recommendation Allowing Older and Immunocompromised Adults to Receive the RSV Vaccine

For the first time in U.S. history, people 60 years and older can now receive a vaccine for protection against the RSV virus.

Source: hhs.gov
CDC Recommends RSV Vaccine For Older Adults | CDC Online Newsroom - Vimarsana News

CDC Recommends RSV Vaccine For Older Adults | CDC Online Newsroom

CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos.

Source: cdc.gov
Manufactured Crisis — HPV, Hype and Horror - Vimarsana News

Manufactured Crisis — HPV, Hype and Horror

We are putting our children not only at risk in all of the ways we've already seen with the adverse events … the autoimmune conditions

FDA's approval of the world's first vaccine against RSV will offer a new tool in an old fight – 4 questions answered - Vimarsana News

FDA's approval of the world's first vaccine against RSV will offer a new tool in an old fight – 4 questions answered

The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.